‡ In these countries please contact our distributor


Transparent Film Roll



OPSITE FLEXIFIX Transparent Film Roll


  • Transparent
  • Conformable
  • Unique roll format


The film is waterproof and a barrier to bacteria. Its high moisture vapour permeability allows the skin to breathe. The acrylic adhesive minimises the risk of skin damage on removal, especially after long periods of wear.

Adaptable to awkward areas
OPSITE FLEXIFIX has been designed to allow easy application of the film to awkward areas of the body and over dressings and tubes. The film is highly conformable and extensible to increase patient comfort.

Unique Roll System
The unique and novel roll format enables rapid and economical use of the OPSITE film to create comfortable, waterproof fixation for dressings.


It can be used for :

  • Retention of primary dressings eg, MELOLITE Low Adherent Dressings or ALLEVYN Hydrocellular Hydrophillic Polyurethane Wound Dressing
  • Fixation of tubing
  • Treatment of painful peripheral neuropathy
  • Skin protection under leg bags, stoma devices etc.
  • Reduction of shearing forces on unbroken skin, e.g. in Pressure Sore Prophylaxis


Ordering information

Catalogue# Size
66000040 5cm x 10m
66000041 10cm x 10m
66000375 15cm x 10mm

Instructions for Use

Step 1

Cut off the desired length of film from roll.

Step 2

Fold the strip along its length to crack the protective papers. Remove the backing paper marked No. 1 "remove first".

Step 3

Apply the adhesive film to desired area and smooth down.

Step 4

Remove the green squared grid carrier, -marked No 3.

Step 5

To remove the film, gently stretch the film parallel to the skin and lift off.

Please see the Overview tab for Contraindications/Precautions

Clinical Support

Paper title: Application of OPSITE FLEXIGRID film a new and effective treatment of painful diabetic neuropathy.

Author: A V M Foster, C Eaton, D O McConville, M E Edmonds

Reference: Diabetic Medicine (1994) 11: 768-772

Study abstract:
The aim of the study was to assess the effect of application of OPSITE* dressings on the pain and quality of life in 33 patients with chronic diabetic neuropathy. The effect of OPSITE was compared with no treatment. After a run-in period of 2 weeks, OPSITE was applied to one of the painful legs for 4 weeks. This was followed by another period of 4 weeks when OPSITE was switched to the opposite leg. Pain was assessed by visual analogue scale and the primary analysis variable was within patient difference in pain between OPSITE leg and no treatment leg as week 4 corrected for baseline. Secondary variables were paracetamol pill ingestion and the quality of life dimensions, sleep, mobility, contact, discomfort, appetite and mood. Changes in these variables from baseline to weeks 4 and 8 were analysed. There was a significantly greater reduction in pain in the OPSITE treated limbs than the control limbs (p < 0.001). by week 4 paracetamol intake also declined significantly (p=0.034) and patients experienced a significant improvement in contact discomfort, sleep, mood, appetite and mobility (P < 0.002 for all 5 variables). OPSITE appeared to alleviate the pain associated with diabetic painful neuropathy and thus improved patient's quality of life.